Angioedema During tPA Treatment

In this context, tPA means a clot-dissolving medicine used in time-sensitive care, including some strokes. The reaction is often called orolingual angioedema because it affects tissues around the mouth and tongue.

Swelling may begin while the medicine is being given or soon afterward. It can be uneven, affecting one side more than the other, and may progress even when there are no hives. Prior use of an ACE inhibitor blood-pressure medicine can increase concern, so the hospital team needs a complete medication history.

Facial weakness from stroke and new tissue swelling are different problems but can coexist. Direct examination of the lips, tongue, voice, swallowing, breathing, and oxygenation helps the team recognise a developing airway reaction.

Tell the bedside team immediately about a thick or tingling tongue, new lip swelling, throat tightness, drooling, voice change, or difficulty swallowing. Do not wait for a routine check, eat, drink, or take a home medicine unless hospital staff instruct you.

A relative can help by naming all current medicines and previous swelling episodes. The treating team will decide whether to pause treatment, give medicines for the reaction, increase monitoring, or prepare airway support while continuing stroke care.

Any new tongue, mouth, or throat swelling during or after tPA is an urgent hospital issue. Noisy or difficult breathing, inability to handle saliva, worsening voice change, reduced alertness, or rapidly expanding swelling demands immediate airway assessment.

After discharge, call UAE emergency services if these symptoms develop or return. Do not drive the affected person, and do not delay because the swelling seems limited to one side.

Ask the hospital team to document the suspected reaction clearly, explain which clot-dissolving medicine was used, review any ACE inhibitor, and state what future emergency teams should know. Clarify whether allergy or specialist follow-up is appropriate for the pattern observed.